A sterility assay was current when the batch-release route began. That evidence expired before commitment. TA-14 preserved the state change, invalidated dependent gates, committed HOLD, blocked release, and closed the outcome with zero product released.
This view answers what was proposed, what governed it, why the decision occurred, whether the decision changed the action path, and what outcome followed.
The route required a current sterility assay, frozen batch and destination identity, valid quality-release authority, preserved continuity, and a final pre-execution revalidation.
The initial assay was valid when captured but no longer current at commit. The expiration event occurred before the route fixed its determination, so the earlier approval could not carry forward into execution.
TA-14 did not treat an earlier valid approval as permanent permission. It preserved the changed evidence validity state, reran dependent gates, committed HOLD, and produced a technical non-release receipt.
This controlled demonstration proves one bounded event through the TA-14 reference engine and adapter. It does not certify every laboratory, manufacturer, batch-release rail, evidence system, or future execution.
TA-14 Exchange Activity
Public activity recorded across the Exchange
—
Visitors
—
Page Views